Your browser doesn't support javascript.
loading
A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%.
Indian J Ophthalmol ; 1996 Jun; 44(2): 87-9
Article in En | IMSEAR | ID: sea-69828
All the presently available antiglaucoma medications have either local or systemic adverse effects. Combinations of drugs are being used not only to increase the effectivity and compliance but also to decrease the incidence and magnitude of side effects. The single dose response of open angle glaucoma eyes to pilocarpine 1%, clonidine 0.125%, a combination of pilocarpine 1% and clonidine 0.125%, and timolol 0.5% was studied in a double blind, masked, cross over study. Over a period of twelve hours the effectivity of the combination of pilocarpine 1% and clonidine 0.125% was significantly more than that of either drug alone and was found to be similar to that of timolol 0.5%. No local or systemic adverse effects were seen.
Subject(s)
Full text: 1 Index: IMSEAR Main subject: Ophthalmic Solutions / Pilocarpine / Timolol / Blood Pressure / Female / Humans / Male / Glaucoma, Open-Angle / Double-Blind Method / Administration, Topical Type of study: Clinical_trials Language: En Journal: Indian J Ophthalmol Year: 1996 Type: Article
Full text: 1 Index: IMSEAR Main subject: Ophthalmic Solutions / Pilocarpine / Timolol / Blood Pressure / Female / Humans / Male / Glaucoma, Open-Angle / Double-Blind Method / Administration, Topical Type of study: Clinical_trials Language: En Journal: Indian J Ophthalmol Year: 1996 Type: Article